Pay in 4 interest-free payments of $5.36 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
A groundbreaking medication approved for chronic weight management and diabetes control
This was an increase of 88.2% or 1.9-fold higher than the rate in 2023, which was 0.5%
Per recent Clarivate estimates, the therapeutic market for these drugs is valued at approximately $1.7 billion1 in 2023 in Mainland China, largely due to the recent success of semaglutide (Novo Nordisks Ozempic) in the country
The combination of inositol and metformin may offer potential additive benefits for insulin resistance and metabolic health , particularly in PCOS management
US$ 26.85
US$ 21.32
US$ 26.48
US$ 25.09
